Literature DB >> 7592823

The amino-terminal immunoglobulin-like domain of sialoadhesin contains the sialic acid binding site. Comparison with CD22.

D Nath1, P A van der Merwe, S Kelm, P Bradfield, P R Crocker.   

Abstract

Sialoadhesin and CD22 are members of a recently characterized family of sialic acid-dependent adhesion molecules belonging to the immunoglobulin superfamily. Sialoadhesin is a macrophage-restricted receptor containing 17 extracellular Ig-like domains which recognizes oligosaccharides terminating in NeuAc alpha 2-3Gal in N- and O-linked glycans. CD22 is a B cell-restricted receptor with seven Ig-like domains which selectively recognizes oligosaccharides terminating in NeuAc alpha 2-6Gal in N-glycans. Sequence similarity between these proteins is highest within their first four amino-terminal Ig-like domains. Here we identify the domain(s) containing the binding sites of both molecules by generating a series of extracellular domain deletion mutants fused to the Fc portion of human IgG1. Binding activity was analyzed by solid phase cell adhesion assays and also by surface plasmon resonance using purified glycophorin and CD45 as ligands for sialoadhesin and CD22, respectively. For sialoadhesin, the amino-terminal V-set Ig-like domain was both necessary and sufficient to mediate sialic acid-dependent adhesion of the correct specificity. In contrast, for murine CD22, only constructs containing both the V-set domain and the adjacent C2-set domain were able to mediate sialic acid-dependent binding. These results are consistent with the sialic acid binding site for both proteins residing in the membrane distal V-set domain, but for CD22 a direct contribution in binding from the neighboring C2-set domain cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592823     DOI: 10.1074/jbc.270.44.26184

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Dependence of surface monoclonal antibody binding on dynamic changes in FcgammaRIIb expression.

Authors:  Jennifer A Walker; Kenneth G C Smith
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

2.  Characterization of the mouse sialoadhesin gene, Sn.

Authors:  S Mucklow; S Gordon; P R Crocker
Journal:  Mamm Genome       Date:  1997-12       Impact factor: 2.957

3.  Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin.

Authors:  D Nath; A Hartnell; L Happerfield; D W Miles; J Burchell; J Taylor-Papadimitriou; P R Crocker
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

Review 4.  The potential role of sialoadhesin as a macrophage recognition molecule in health and disease.

Authors:  P R Crocker; A Hartnell; J Munday; D Nath
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

5.  Molecular analysis of sialoside binding to sialoadhesin by NMR and site-directed mutagenesis.

Authors:  P R Crocker; M Vinson; S Kelm; K Drickamer
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

6.  Multivalent ligands for siglecs.

Authors:  Mary K O'Reilly; James C Paulson
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

7.  CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics.

Authors:  P A van der Merwe; D L Bodian; S Daenke; P Linsley; S J Davis
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

Review 8.  Sialoadhesin in recognition of self and non-self.

Authors:  Mariliis Klaas; Paul R Crocker
Journal:  Semin Immunopathol       Date:  2012-03-27       Impact factor: 9.623

Review 9.  CD22: an inhibitory enigma.

Authors:  Jennifer A Walker; Kenneth G C Smith
Journal:  Immunology       Date:  2007-12-07       Impact factor: 7.397

10.  Porcine arterivirus attachment to the macrophage-specific receptor sialoadhesin is dependent on the sialic acid-binding activity of the N-terminal immunoglobulin domain of sialoadhesin.

Authors:  Peter L Delputte; Wander Van Breedam; Iris Delrue; Cornelia Oetke; Paul R Crocker; Hans J Nauwynck
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.